Organon OGN Implanon — Number of pending claims
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:LossContingencyPendingClaimsNumber.
The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organon's implanon — number of pending claims.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Organon's implanon — number of pending claims?
- Organon (OGN) reported implanon — number of pending claims of $2 in Q1 2026.
- How has Organon's implanon — number of pending claims changed year-over-year?
- Organon's implanon — number of pending claims decreased by 0.0% year-over-year, from $2 to $2.
- What is the long-term trend for Organon's implanon — number of pending claims?
- Over 4 years (2021 to 2025), Organon's implanon — number of pending claims has grown at a 0.0% compound annual growth rate (CAGR), from $8 to $8.
- What does implanon — number of pending claims mean?
- This metric represents the total volume of insurance or reimbursement claims for the Implanon contraceptive product that have been submitted but are currently awaiting final adjudication or payment from payers. Monitoring this figure helps assess the efficiency of the revenue cycle and identifies potential bottlenecks in the reimbursement process for women's health products. A high volume of pending claims may indicate administrative delays or evolving payer coverage policies that could impact short-term cash flow.